Belladonna
Belladonna is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| belladonna alkaloids with phenobartbital | unapproved drug other | 2013-08-21 |
| belladonna and opium | unapproved drug other | 2024-01-11 |
| contac gold | OTC monograph final | 2019-03-18 |
| migraine pack | ANDA | 2017-01-13 |
| phenobarbital with belladonna alkaloids | unapproved drug other | 2020-08-05 |
| re-pb hyos elixir | unapproved drug other | 2011-01-26 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A03: Drugs for functional gastrointestinal disorders
— A03B: Belladonna and derivatives containing drugs, plain for functional gastrointestinal disorders
— A03BA: Belladonna alkaloids, tertiary amines for functional gastrointestinal disorders
— A03BA04: Belladonna total alkaloids
— A03BB: Belladonna alkaloids, semisynthetic, quaternary ammonium compounds for functional gastrointestinal disorders
— A03C: Antispasmodics in combination with psycholeptics
— A03CB: Belladonna and derivatives in combination with psycholeptics
— A03CB02: Belladonna total alkaloids and psycholeptics
— A03D: Antispasmodics in combination with analgesics
— A03DB: Belladonna and derivatives in combination with analgesics
— A06: Drugs for constipation
— A06A: Drugs for constipation
— A06AB: Contact laxatives
— A06AB30: Contact laxatives in combination with belladonna alkaloids
HCPCS
No data
Clinical
Clinical Trials
330 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 3 | 7 | 13 | 16 | 15 | 54 |
| Myopia | D009216 | EFO_0003927 | H52.1 | 7 | 7 | 8 | 6 | 13 | 39 |
| Asthma | D001249 | EFO_0000270 | J45 | 1 | 2 | 2 | 9 | 5 | 19 |
| Healthy volunteers/patients | — | — | — | 8 | — | — | 1 | 2 | 11 |
| Neuromuscular blockade | D019148 | — | — | 1 | 3 | 2 | 6 | — | 11 |
| Bradycardia | D001919 | — | R00.1 | — | 1 | — | 7 | 3 | 11 |
| Amblyopia | D000550 | — | H53.00 | — | — | 7 | 1 | 1 | 9 |
| Nausea | D009325 | — | R11.0 | — | — | — | 4 | 4 | 8 |
| Pain | D010146 | EFO_0003843 | R52 | 1 | — | 1 | 4 | 2 | 8 |
| Vomiting | D014839 | — | R11.1 | — | — | — | 3 | 3 | 6 |
Show 70 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Motion sickness | D009041 | — | T75.3 | 1 | 4 | 7 | — | — | 10 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | — | 1 | 3 | — | 4 | 8 |
| Obstructive lung diseases | D008173 | — | — | — | 2 | 1 | — | 4 | 7 |
| General anesthesia | D000768 | — | — | — | 2 | 2 | — | 2 | 6 |
| Anesthesia | D000758 | — | — | — | — | 2 | — | 3 | 5 |
| Organophosphate poisoning | D062025 | — | — | 1 | 2 | 2 | — | — | 4 |
| Premedication | D011292 | — | — | — | 2 | 2 | — | — | 2 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 1 | — | — | 2 |
| Abdominal pain | D015746 | EFO_0003766 | R10.9 | — | — | 1 | — | 1 | 2 |
| Hypospadias | D007021 | EFO_0004209 | Q54 | — | 1 | 1 | — | — | 1 |
Show 17 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sialorrhea | D012798 | — | K11.7 | 1 | 3 | — | — | 2 | 5 |
| Degenerative myopia | D047728 | — | H44.2 | 2 | 2 | — | — | 1 | 4 |
| Heart arrest | D006323 | EFO_0009492 | I46 | — | 1 | — | — | 1 | 2 |
| Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | 2 | — | — | — | 2 |
| Space motion sickness | D018489 | EFO_1001188 | — | — | 2 | — | — | — | 2 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | 1 | — | — | — | 1 |
| Hemostatic disorders | D020141 | — | — | — | 1 | — | — | — | 1 |
| Heart valve diseases | D006349 | EFO_0009551 | I08 | — | 1 | — | — | — | 1 |
| Treatment-resistant schizophrenia | D000090663 | — | — | 1 | 1 | — | — | — | 1 |
| Amyotrophic lateral sclerosis | D000690 | EFO_0000253 | G12.21 | — | 1 | — | — | — | 1 |
Show 14 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | 2 | — | — | — | 1 | 3 |
| Prediabetic state | D011236 | EFO_1001121 | R73.03 | 1 | — | — | — | 1 | 2 |
| Hypoglycemia | D007003 | — | E16.2 | 2 | — | — | — | — | 2 |
| Memory disorders | D008569 | — | — | 2 | — | — | — | — | 2 |
| Pulmonary atelectasis | D001261 | — | J98.1 | 1 | — | — | — | 1 | 2 |
| Dementia | D003704 | EFO_0003862 | F03 | 2 | — | — | — | — | 2 |
| Status asthmaticus | D013224 | — | — | 1 | — | — | — | — | 1 |
| Glucose intolerance | D018149 | HP_0000833 | R73.03 | 1 | — | — | — | — | 1 |
| Digestive system physiological phenomena | D004068 | — | — | 1 | — | — | — | — | 1 |
| Gastrointestinal motility | D005769 | — | — | 1 | — | — | — | — | 1 |
Show 15 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | — | — | — | 2 | 2 |
| Rhytidoplasty | D015361 | — | — | — | — | — | — | 1 | 1 |
| Blood coagulation tests | D001780 | — | — | — | — | — | — | 1 | 1 |
| Postoperative cognitive complications | D000079690 | — | — | — | — | — | — | 1 | 1 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | — | — | — | 1 | 1 |
| Urinary bladder neoplasms | D001749 | — | C67 | — | — | — | — | 1 | 1 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 1 | 1 |
| Vascular diseases | D014652 | EFO_0004264 | I77 | — | — | — | — | 1 | 1 |
| Sudden death cardiac | D016757 | EFO_0004278 | — | — | — | — | — | 1 | 1 |
| Common cold | D003139 | EFO_0007214 | J00 | — | — | — | — | 1 | 1 |
Show 28 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Belladonna |
| INN | — |
| Description | Belladonna or Bella Donna may refer to:
|
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108906 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Belladonna
+
Butabarbital
+
Atropa belladonna
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Belladonna
+
Ergotamine
+
Phenobarbital
+
Atropa belladonna
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
Black-box warning for: Belladonna alkaloids with phenobartbital, Belladonna and opium
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
871 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use